Animal experiments have demonstrated that oxidative stress, gut microbiota, glutamatergic transmission, and oxytocin signaling can modulate amygdala activity, providing direct evidence for neuro-immune-metabolic integration in depression pathophysiology (61–63). This evidence concerns the gene OXT and depressive disorder.